Protective effects of relaxin in ischemia/reperfusion-induced intestinal injury due to splanchnic artery occlusion

British Journal of Pharmacology

Volumn 148, Issue 8, 2006, Pages 1124-1132

  Masini, Emanuela ^a   Cuzzocrea, Salvatore ^b,c   Mazzon, Emanuela ^b,c   Muià, Carmelo ^b   Vannacci, Alfredo ^a   Fabrizi, Francesca ^a   Bani, Daniele ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Apoptosis; Endothelial cell adhesion molecules; Oxygen free radicals; Relaxin; Splanchnic artery occlusion

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; CASPASE 3; CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; DNA; ENDOTHELIAL CELL ADHESION MOLECULE; FREE RADICAL; MALONALDEHYDE; MYELOPEROXIDASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); RELAXIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY OCCLUSION; ARTICLE; CELL INFILTRATION; CELL PROTECTION; CONTROLLED STUDY; DISEASE MODEL; DNA DAMAGE; DRUG EFFECT; DRUG INACTIVATION; ENDOTHELIUM INJURY; HISTOPATHOLOGY; ILEUM; INTESTINE CELL; INTESTINE INJURY; INTESTINE ISCHEMIA; LEUKOCYTE; NICK END LABELING; NITRATION; NONHUMAN; PATHOPHYSIOLOGY; PEROXIDATION; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SHOCK; SPLANCHNIC ARTERY OCCLUSION; SPLANCHNIC BLOOD FLOW;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTESTINES; MALONDIALDEHYDE; PEROXIDASE; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, WISTAR; RELAXIN; REPERFUSION INJURY; SPLANCHNIC CIRCULATION; SUPEROXIDE DISMUTASE;

EID: 33747133303     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706811     Document Type: Article

References (69)

1. ALTURA, B.M., GEBREWOLDA, A. & BURTON, R.W. (1985). Reactive hyperaemic responses of single arterioles are attenuated markedly after intestinal ischemia, endotoxemia and traumatic shock: possible role of endothelial cells. Microcirc. Endoth. Lymp., 2, 3-14.
2. BANI, D. (1997). Relaxin: a pleiotropic hormone. Gen. Pharmacol., 28, 13-22.
3. BANI, D., FAILLI, P., BELLO, M.G., THIEMERMANN, C., BANI SACCHI, T., BIGAZZI, M. & MASINI, E. (1998a). Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture. Hypertension, 31, 1240-1247.
4. BANI, D., MASINI, E., BELLO, M.G., BIGAZZI, M. & BANI SACCHI, T. (1998b). Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart. Am. J. Pathol., 152, 1367-1376.
5. BITTERMANN, H., AOKI, N. & LEFER, A.M. (1988). Anti-shock effects of human superoxide dismutase in splanchnic occlusion shock. Proc. Soc. Exp. Biol. Med., 188, 256-271.
6. BOUGHTON-SMITH, N.K., EVANS, S.M., LASZLO, F., WHITTLE, B.J. & MONCADA, S. (1993). The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br. J. Pharmacol., 110, 1189-1195.
7. BÜLLESBACH, E.E. & SCHWABE, C. (1988). On the receptor binding sites of relaxins. Int. J. Pept. Protein. Res., 32, 361-367.
8. BUTCHER, E.C. (1992). Leukocyte-endothelial cell adhesion as an active, multi-step process: a combinatorial mechanism for specificity and diversity in leukocyte targeting. Adv. Exp. Med. Biol., 323, 181-194.
9. BUTCHER, E.C. (1993). Specificity of leukocyte-endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision process. Res. Immunol., 144, 695-698.
10. CAREY, C., SIEGFRIED, M.R., MA, X.L., WEYRICH, A.S. & LEFER, A.M. (1992). Antishock and endothelial protective actions of a NO donor in mesenteric and reperfusion. Circ. Shock, 38, 209-216.
11. CHEN, S.A., PERLMAN, A.J., SPANSKI, N., PETERSON, C.M., SANDERS, S.W., JAFFE, R., MARTIN, M., YALCINKAYA, T., CEFALO, R.C., CHESCHEIR, N.C., MENARD, M.K. & MORDENTI, J. (1993). The pharmacokinetics of recombinant human relaxin in nonpregnant women after intravenous, intravaginal, and intracervical administration. Pharm. Res., 10, 834-838.
12. CROW, J.P. & BECKMAN, J.S. (1995). The role of peroxynitrite in nitric oxide-mediated toxicity. Curr. Top Microbiol. Immunol., 196, 57-73.
13. CUZZOCREA, S., MAZZON, E., DUGO, L., CAPUTI, A.P., ASTON, K., RILEY, D.P. & SALVEMINI, D. (2001). Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br. J. Pharmacol., 132, 19-29.
14. CUZZOCREA, S., ZINGARELLI, B., COSTANTINO, G., SZABÓ, A., SALZMAN, A.L., CAPUTI, A.P. & SZABÓ, C. (1997). Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion. Br. J. Pharmacol., 121, 1065-1074.
15. DEITCH, E.A., BRIDGES, W., BERG, R., SPECIAN, R.D. & GRANGER, N. (1990). Hemorrhagic Shock-induced bacterial translocation: the role of neutrophils and hydroxyl radicals. J. Trauma, 30, 942-951.
16. DIX, T.A., HESS, K.M., MEDINA, M.A., SULLIVAN, R.W., TILLY, S.L. & WEBB, T.L.L. (1996). Mechanism of site-selective DNA nicking by the hydrodioxyl (perhydroxyl) radical. Biochemistry, 35, 4578-4583.
17. DROY-LEFAIX, M.T., DROUET, Y., GERAUD, G., HOSFOD, D. & BRAQUET, P. (1991). Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion. Free Rad. Res. Commun., 12-13, 725-735.
18. DSCHIETZIG, T. & STANGL, K. (2002). Relaxin: a pregnancy hormone as a central player of body fluid and circulation homeostasis. Cell Mol Life Sci., 59, 1-13.
19. DSCHIETZIG, T., BARTSCH, C., STANGL, V., BAUMANN, G. & STANGL, K. (2004). Identification of the pregnancy hormone relaxin as glucocorticoid receptor agonist. FASEB J., 13, 1536-1538.
20. EISSERICH, J.P., HRISTOVA, M., CROSS, C.E., JONES, A.D., FREEMAN, B.A., HALLIWELL, B. & VAN DER VLIET, A. (1998). Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature, 391, 393-397.
21. FAILLI, P., NISTRI, S., QUATTRONE, S., MAZZETTI, L., BIGAZZI, M., BANI SACCHI, T. & BANI, D. (2002). Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells. FASEB J., 16, 252-254.
22. FANTONE, J.C. & WARD, P.A. (1982). A review: role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol., 107, 395-418.
23. GAUTHIER, T.W., DAVENPECK, K.L. & LEFER, A.M. (1994). Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am. J. Physiol., 267, 562-568.
24. GRANGER, D.N. (1977). Cell adhesion and migration. II. Leukocyte-endothelial cell adhesion in the digestive system. Am. J. Physiol., 273, G982-G986.
25. GRANGER, D.N., RUTILI, G. & MCCORD, J.M. (1981). Superoxide radicals in feline intestinal ischemia. Gastroenterology, 81, 22-23.
26. HAGLIND, E., XIA, G. & RYLANDER, R. (1994). Effects of antioxidants and PAF receptor antagonist in intestinal shock in the rat. Circ. Shock., 42, 83-91.
27. HARLAN, J.M. (1985). Leukocyte-endothelial interactions. Blood, 65, 513-525.
28. INOUE, S. & KAWANISHI, S. (1995). Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett., 371, 86-88.
29. KALIA, N., BROWN, N.J., HOPKINSON, K., STEPHENSON, T.J., WOOD, R.F. & POCKLEY, A.G. (2002). FK409 inhibits both local and remote organ damage after intestinal ischaemia. J. Pathol., 197, 595-602.
30. KANWAR, S., TEPPERMAN, B.L., PAYNE, D., SUTHERLAND, L.R. & KUBES, P. (1994). Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ. Shock, 42, 135-140.
31. KUBES, P., SUZUKI, M. & GRANGER, D.N. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A., 88, 4651-4655.
32. LAROUX, F.S., LEFER, D.J., KAWACHI, S., SCALIA, R., COCKRELL, A.S., GRAY, L., VAN DER HEYDE, H., HOFFMANN, J.M. & GRISHAM, M.B. (2000). Role of nitric oxide in the regulation of acute and chronic inflammation. Antiox. Redox. Signal, 2, 391-396.
33. LAWRENCE, M.B. & SPRINGER, T.A. (1991). Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell, 65, 859-873.
34. LEFER, A.M. & LEFER, D.J. (1993). Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Ann. Rev. Pharmacol. Toxicol., 33, 71-90.
35. LEFER, D.J., JONES, S.P., GIROD, W.G., BAINES, A., GRISHAM, M.B., COCKRELL, A.S., HUANG, P.L. & SCALIA, R. (1999). Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am. J. Physiol., 276, H1943-H1950.
36. LODOVICI, M., CASALINI, C., CARIEGGI, R., MICHELACCI, L. & DOLARA, P. (2000). Levels of 8-hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes. Free Rad. Biol.Med., 28, 13-17.
37. MALLICK, I.H., YANG, W., WINSLET, M.C. & SEIFALIAN, A.M. (2004). Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig. Dis. Sci., 49, 1359-1377.
38. MASINI, E., BANI, D., BELLO, M.G., BIGAZZI, M., MANNAIONI, P.F. & BANI SACCHI, T. (1997). Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide. Endocrinology, 138, 4713-4720.
39. MASINI, E., NISTRI, S., VANNACCI, A., BANI SACCHI, T., NOVELLI, A. & BANI, D. (2004). Relaxin inhibits the activation of human neutrophils. Involvement of the nitric oxide pathway. Endocrinology, 145, 1106-1112.
40. McCORD, J.M. (1981). Oxygen-derived free radicals in post ischemic tissue injury. N. Engl. J. Med., 312, 159-163.
41. MISKO, T.P., HIGHKIN, M.K., VEENHUIZEN, A.W., MANNING, P.T., STERN, M.K., CURRIE, M.G. & SALVEMINI, D. (1998). Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem., 273, 15646-15653.
42. MULLANE, K.M., KRAEMER, R. & SMITH, B. (1985). Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods, 14, 157-167.
43. MULLANE, K.M., WESTLIN, W. & KRAEMER, R. (1988). Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. Ann. NY Acad. Sci., 524, 103-121.
44. NISHIDA, S., TERAMOTO, K., KIMOTO-KINOSHITA, S., TOHDA, Y., NAKAJIMA, S., TOMURA, T.T. & IRIMAJIRI, K. (2002). Changes of Cu,Zn-superoxide dismutase activity of guinea pig lung in experimental asthma. Free Radical. Res., 36, 601-606.
45. NISTRI, S. & BANI, D. (2005). Relaxin in vascular physiology and pathophysiology: possible implications in ischemic brain disease. Curr. Neurovasc. Res., 2, 225-234.
46. NISTRI, S., CHIAPPINI, L., SASSOLI, C. & BANI, D. (2003). Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide-mediated mechanism. FASEB J., 17, 2109-2111.
47. OHKAWA, H., OHISHI, N. & YAGI, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351-358.
48. PENG, H.B., SPIECKER, M. & LIAO, J.K. (1998). Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J. Immunol., 161, 1970-1976.
49. PERNA, A.M., MASINI, E., NISTRI, S., BRIGANTI, V., CHIAPPINI, L., STEFANO, P., BIGAZZI, M., PIERONI, C., BANI SACCHI, T. & BANI, D. (2005). Novel drug development opportunity for relaxin in acute myocardial infarction. Evidences from a swine model. FASEB J., 19, 1525-1527.
50. RATYCH, R.E., CHUKNYSKA, R.S. & BURKLEY, G.B. (1987). The primary localisation of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery, 102, 122-131.
51. SALGO, M.G., BERMUDEZ, E., SQUADRITO, G. & PRYOR, W. (1995). DNA damage and oxidation of thiols peroxynitrite causes in rat thymocytes. Arch. Biochem. Biophys., 322, 500-505.
52. SALVEMINI, D., MISKO, T.P., MASFERRER, J., SEIBERT, K., CURRIE, M.G. & NEEDLEMAN, P. (1993). Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U.S.A., 90, 7240-7244.
53. SALVEMINI, D., RILEY, D.P., LENNON, P.J., WANG, Z.Q., CURRIE, M.G., MACARTHUR, H. & MISKO, T.P. (1999a). Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br. J. Pharmacol., 127, 685-692.
54. SALVEMINI, D., WANG, Z.Q., WYATT, P., BOURDON, D.M., MARINO, M.H., MANNING, P.T. & CURRIE, M.G. (1996). Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol., 118, 829-838.
55. SALVEMINI, D., WANG, Z.Q., ZWEIER, J.L., SAMOUILOV, A., MACARTHUR, H., MISKO, T.P., CURRIE, M.G., CUZZOCREA, S., SIKORSKI, J.A. & RILEY, D.P. (1999b). A nonpeptidyl mimetic of superoxide dismutase with therapeutic activity in rats. Science, 286, 304-306.
56. SAMUEL, C., PARRY, L.J. & SUMMERS, R.J. (2003). Physiological or pathological - a role for relaxin in the cardiovascular system? Curr. Opin. Pharmacol., 3, 152-158.
57. SHERWOOD, O.D. (2004). Relaxin's physiological roles and other diverse actions. Endocr. Rev., 25, 205-234.
58. SHERWOOD, O.D. & O'BYRNE, E.M. (1974). Purification and characterization of porcine relaxin. Arch. Biochem. Biophys., 60, 185-196.
59. SLUITER, W., PIETERSMA, A., LAMERS, J.M.J. & KOSTER, J.F. (1993). Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanism underlying their expression. J. Cardiovasc. Pharmacol., 22 (Suppl. 4), S37-S44.
60. SPIECKER, M. & LIAO, J.K. (1999). Assessing induction of I kappa B by nitric oxide. Methods Enzymol., 300, 374-388.
61. SREENARASIMHAIAH, J. (2005). Diagnosis and management of ischemic colitis. Curr. Gastroenterol. Rep., 7, 421-426.
62. STENNICKE, H.R. & SALVESEN, G.S. (1997). Biochemical characteristics of caspases-3, -6, -7, and -8. J. Biol. Chem., 272, 25719-25723.
63. STONEY, R.J. & CUNNINGHAN, C.G. (1993). Acute mesenteric ischemia. Surgery, 114, 489-490.
64. SZABÓ, C., CUZZOCREA, S., ZINGARELLI, B., O'CONNOR, M. & SALZMAN, A.L. (1997). Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) polymerase by peroxynitrite.. J. Clin. Invest., 100, 723-735.
65. SZABÓ, C. & DAWSON, V.L. (1998). Role of poly(ADP-ribose) polymerase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci., 19, 287-298.
66. WARD, D.T., LAWSON, S.A., GALLAGHER, C.M., CONNER, W.C. & SHEA-DONOHUE, T. (2000). Sustained nitric oxide production via L-arginine administration ameliorates effects of intestinal ischemia-reperfusion. J. Surg. Res., 89, 13-19.
67. XIA, Z.F., HOLLYOAK, M., BARROW, R.E., HE, F., MULLER, M.J. & HERNDON, D.N. (1995). Superoxide dismutase and leupeptin prevent delayed reperfusion injury in the rat small intestine during burn shock. J. Burn Care Rehab., 16, 111-117.
68. ZIMMERMANN, B.J., ARNDT, H., KUBES, P., KURTEL, H. & GRANGER, D.N. (1993). Reperfusion injury in the small intestine. In Pathophysiology of Shock, Sepsis and Organ Failure, eds. SCHLAG, G., & REDL, H., pp. 322-335. Berlin, Germany: Springer-Verlag.
69. ZINGARELLI, B., SQUADRITO, F., INOCULANO, M.P., ALTAVILLA, D., BUSSOLINO, F., CAMPO, G.M. & CAPUTI, A.P. (1992). Platelet activating factor in splanchnic artery occlusion shock. Eur. J. Pharmacol., 222, 13-19.